Malaria in β-thalassemic mice and the effects of the transgenic human β-globin gene and splenectomy

Eugene F. Roth, Hannah L. Shear, Frank Costantini, Herbert B. Tanowitz, Ronald L. Nagel

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

To investigate the protective effects of β-thalassemia against malaria, rodent malaria parasites were studied in C57BL/6J mice with β-thalassemia, in mice in which the thalassemia had been transgenically corrected with the human βA-globin gene, and in hematologically normal mice. In thalassemic mice, Plasmodium chabaudi adami infection was inhibited and peak parasitemia was variably delayed. In transgenically corrected mice, infection proceeded as in normal mice. Plasmodium berghei infection proceeded more rapidly in thalassemic mice, but survival was not different. Splenectomized normal mice displayed high-level parasitemia that peaked twice and persisted as a low-level parasitemia for more than 20 days after normal intact mice were free of all parasites. Splenectomized thalassemic mice showed a delay of 5 days in attaining peak parasitemia, but the parasitemia persisted as in normal splenectomized mice. Thus, for P. chabaudi, which displayed no preference for immature erythrocytes, β-thalassemia offers enhanced resistance for the host. However, for P. berghei, which preferentially invades reticulocytes, thalassemia is not protective. The protective effects of the normal mouse spleen were observed, but the paradoxical facilitation of parasite growth by the thalassemic spleen is a new finding that will require further experimentation to explain. This new in vivo laboratory documentation of thalassemic protection against some rodent malaria parasites may serve as a useful model in further efforts to control this major infectious disease.

Original languageEnglish (US)
Pages (from-to)35-41
Number of pages7
JournalThe Journal of Laboratory and Clinical Medicine
Volume111
Issue number1
StatePublished - 1988

Fingerprint

Globins
Splenectomy
Transgenic Mice
Malaria
Genes
Thalassemia
Parasitemia
Parasites
Plasmodium chabaudi
Plasmodium berghei
Rodentia
Spleen
Reticulocytes
Infection
Inbred C57BL Mouse
Documentation
Communicable Diseases
Erythrocytes

ASJC Scopus subject areas

  • Medicine(all)
  • Pathology and Forensic Medicine

Cite this

Roth, E. F., Shear, H. L., Costantini, F., Tanowitz, H. B., & Nagel, R. L. (1988). Malaria in β-thalassemic mice and the effects of the transgenic human β-globin gene and splenectomy. The Journal of Laboratory and Clinical Medicine, 111(1), 35-41.

Malaria in β-thalassemic mice and the effects of the transgenic human β-globin gene and splenectomy. / Roth, Eugene F.; Shear, Hannah L.; Costantini, Frank; Tanowitz, Herbert B.; Nagel, Ronald L.

In: The Journal of Laboratory and Clinical Medicine, Vol. 111, No. 1, 1988, p. 35-41.

Research output: Contribution to journalArticle

Roth, EF, Shear, HL, Costantini, F, Tanowitz, HB & Nagel, RL 1988, 'Malaria in β-thalassemic mice and the effects of the transgenic human β-globin gene and splenectomy', The Journal of Laboratory and Clinical Medicine, vol. 111, no. 1, pp. 35-41.
Roth, Eugene F. ; Shear, Hannah L. ; Costantini, Frank ; Tanowitz, Herbert B. ; Nagel, Ronald L. / Malaria in β-thalassemic mice and the effects of the transgenic human β-globin gene and splenectomy. In: The Journal of Laboratory and Clinical Medicine. 1988 ; Vol. 111, No. 1. pp. 35-41.
@article{cc1bccd4acb240e8985b19db0820bdfa,
title = "Malaria in β-thalassemic mice and the effects of the transgenic human β-globin gene and splenectomy",
abstract = "To investigate the protective effects of β-thalassemia against malaria, rodent malaria parasites were studied in C57BL/6J mice with β-thalassemia, in mice in which the thalassemia had been transgenically corrected with the human βA-globin gene, and in hematologically normal mice. In thalassemic mice, Plasmodium chabaudi adami infection was inhibited and peak parasitemia was variably delayed. In transgenically corrected mice, infection proceeded as in normal mice. Plasmodium berghei infection proceeded more rapidly in thalassemic mice, but survival was not different. Splenectomized normal mice displayed high-level parasitemia that peaked twice and persisted as a low-level parasitemia for more than 20 days after normal intact mice were free of all parasites. Splenectomized thalassemic mice showed a delay of 5 days in attaining peak parasitemia, but the parasitemia persisted as in normal splenectomized mice. Thus, for P. chabaudi, which displayed no preference for immature erythrocytes, β-thalassemia offers enhanced resistance for the host. However, for P. berghei, which preferentially invades reticulocytes, thalassemia is not protective. The protective effects of the normal mouse spleen were observed, but the paradoxical facilitation of parasite growth by the thalassemic spleen is a new finding that will require further experimentation to explain. This new in vivo laboratory documentation of thalassemic protection against some rodent malaria parasites may serve as a useful model in further efforts to control this major infectious disease.",
author = "Roth, {Eugene F.} and Shear, {Hannah L.} and Frank Costantini and Tanowitz, {Herbert B.} and Nagel, {Ronald L.}",
year = "1988",
language = "English (US)",
volume = "111",
pages = "35--41",
journal = "Translational Research",
issn = "1931-5244",
publisher = "Mosby Inc.",
number = "1",

}

TY - JOUR

T1 - Malaria in β-thalassemic mice and the effects of the transgenic human β-globin gene and splenectomy

AU - Roth, Eugene F.

AU - Shear, Hannah L.

AU - Costantini, Frank

AU - Tanowitz, Herbert B.

AU - Nagel, Ronald L.

PY - 1988

Y1 - 1988

N2 - To investigate the protective effects of β-thalassemia against malaria, rodent malaria parasites were studied in C57BL/6J mice with β-thalassemia, in mice in which the thalassemia had been transgenically corrected with the human βA-globin gene, and in hematologically normal mice. In thalassemic mice, Plasmodium chabaudi adami infection was inhibited and peak parasitemia was variably delayed. In transgenically corrected mice, infection proceeded as in normal mice. Plasmodium berghei infection proceeded more rapidly in thalassemic mice, but survival was not different. Splenectomized normal mice displayed high-level parasitemia that peaked twice and persisted as a low-level parasitemia for more than 20 days after normal intact mice were free of all parasites. Splenectomized thalassemic mice showed a delay of 5 days in attaining peak parasitemia, but the parasitemia persisted as in normal splenectomized mice. Thus, for P. chabaudi, which displayed no preference for immature erythrocytes, β-thalassemia offers enhanced resistance for the host. However, for P. berghei, which preferentially invades reticulocytes, thalassemia is not protective. The protective effects of the normal mouse spleen were observed, but the paradoxical facilitation of parasite growth by the thalassemic spleen is a new finding that will require further experimentation to explain. This new in vivo laboratory documentation of thalassemic protection against some rodent malaria parasites may serve as a useful model in further efforts to control this major infectious disease.

AB - To investigate the protective effects of β-thalassemia against malaria, rodent malaria parasites were studied in C57BL/6J mice with β-thalassemia, in mice in which the thalassemia had been transgenically corrected with the human βA-globin gene, and in hematologically normal mice. In thalassemic mice, Plasmodium chabaudi adami infection was inhibited and peak parasitemia was variably delayed. In transgenically corrected mice, infection proceeded as in normal mice. Plasmodium berghei infection proceeded more rapidly in thalassemic mice, but survival was not different. Splenectomized normal mice displayed high-level parasitemia that peaked twice and persisted as a low-level parasitemia for more than 20 days after normal intact mice were free of all parasites. Splenectomized thalassemic mice showed a delay of 5 days in attaining peak parasitemia, but the parasitemia persisted as in normal splenectomized mice. Thus, for P. chabaudi, which displayed no preference for immature erythrocytes, β-thalassemia offers enhanced resistance for the host. However, for P. berghei, which preferentially invades reticulocytes, thalassemia is not protective. The protective effects of the normal mouse spleen were observed, but the paradoxical facilitation of parasite growth by the thalassemic spleen is a new finding that will require further experimentation to explain. This new in vivo laboratory documentation of thalassemic protection against some rodent malaria parasites may serve as a useful model in further efforts to control this major infectious disease.

UR - http://www.scopus.com/inward/record.url?scp=0023845116&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023845116&partnerID=8YFLogxK

M3 - Article

VL - 111

SP - 35

EP - 41

JO - Translational Research

JF - Translational Research

SN - 1931-5244

IS - 1

ER -